Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Journal

Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 31 5 2019
medline: 31 5 2019
entrez: 1 6 2019
Statut: ppublish

Résumé

A correction to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41388-019-0835-1 PMID: 31147600 PMC: PMC7608239
pubmed: 31147600
doi: 10.1038/s41388-019-0835-1
pii: 10.1038/s41388-019-0835-1
pmc: PMC7608239
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

5746

Commentaires et corrections

Type : ErratumFor

Auteurs

Steve Wagner (S)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Georgios Vlachogiannis (G)

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

Alexis De Haven Brandon (A)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Melanie Valenti (M)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Gary Box (G)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Liam Jenkins (L)

Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.

Caterina Mancusi (C)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Annette Self (A)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Floriana Manodoro (F)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Ioannis Assiotis (I)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Penny Robinson (P)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Ritika Chauhan (R)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Alistair G Rust (AG)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Nik Matthews (N)

Tumour Profiling Unit, The Institute of Cancer Research, London, UK.

Kate Eason (K)

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0001-6903-9067

Khurum Khan (K)

Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

Naureen Starling (N)

Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

David Cunningham (D)

Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

Anguraj Sadanandam (A)

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

Clare M Isacke (CM)

Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.

Vladimir Kirkin (V)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.

Nicola Valeri (N)

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

Steven R Whittaker (SR)

Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK. steven.whittaker@icr.ac.uk.
ORCID: 0000-0001-9062-7947

Classifications MeSH